Page last updated: 2024-10-29

avapro and Coronary Disease

avapro has been researched along with Coronary Disease in 4 studies

Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.

Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.

Research Excerpts

ExcerptRelevanceReference
"Patients with high blood pressure are often overweight or even obese."2.71[Arterial hypertension in obese patients. Rationale for a prospective medical care study in the family doctor's practice]. ( Bramlage, P; Kirch, W; Sharma, AM, 2004)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lauten, WB1
Khan, QA1
Rajagopalan, S1
Lerakis, S1
Rahman, ST1
Parthasarathy, S1
Khan, BV1
Bramlage, P1
Sharma, AM1
Kirch, W1
Morawietz, H1
Erbs, S1
Holtz, J1
Schubert, A1
Krekler, M1
Goettsch, W1
Kuss, O1
Adams, V1
Lenk, K1
Mohr, FW1
Schuler, G1
Hambrecht, R1
Tousoulis, D1
Kourtellaris, P1
Antoniades, C1
Vasiliadou, C1
Papageorgiou, N1
Tentolouris, C1
Siasos, G1
Stefanadi, E1
Stefanadis, C1

Trials

3 trials available for avapro and Coronary Disease

ArticleYear
[Arterial hypertension in obese patients. Rationale for a prospective medical care study in the family doctor's practice].
    MMW Fortschritte der Medizin, 2004, Aug-05, Volume: 146 Suppl 2

    Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Biphenyl Compounds; C

2004
Endothelial Protection, AT1 blockade and Cholesterol-Dependent Oxidative Stress: the EPAS trial.
    Circulation, 2006, Jul-04, Volume: 114, Issue:1 Suppl

    Topics: Angiotensin II Type 1 Receptor Blockers; Atherosclerosis; Biphenyl Compounds; Blood Pressure; Choles

2006
Effects of irbesartan and perindopril on forearm reactive hyperemia and inflammatory process, in normotensive patients with coronary artery disease.
    International journal of cardiology, 2008, Feb-20, Volume: 124, Issue:1

    Topics: Antihypertensive Agents; Biphenyl Compounds; Blood Flow Velocity; Coronary Disease; E-Selectin; Enzy

2008

Other Studies

1 other study available for avapro and Coronary Disease

ArticleYear
Usefulness of quinapril and irbesartan to improve the anti-inflammatory response of atorvastatin and aspirin in patients with coronary heart disease.
    The American journal of cardiology, 2003, May-01, Volume: 91, Issue:9

    Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents

2003